You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

SYSTEMATIC REVIEW article

Front. Med., 29 October 2025

Sec. Geriatric Medicine

Volume 12 - 2025 | https://doi.org/10.3389/fmed.2025.1646903

Evaluation of the efficacy of physical agent modalities in patients with fractures: a systematic review and network meta-analysis

  • 1. Rehabilitation Medicine Department, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China

  • 2. Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China

  • 3. Department of Rehabilitation Medicine, Southwest Medical University, Luzhou, Sichuan, China

  • 4. Rehabilitation Medicine and Engineering Key Laboratory of Luzhou, Luzhou, Sichuan, China

Article metrics

View details

1,7k

Views

89

Downloads

Abstract

Background:

Fractures are increasing due to ageing populations. Physical agent modalities, a non-invasive treatment, enhances healing and reduces non-union risk.

Objective:

This meta-analysis evaluates the effectiveness of physical agent modalities in patients with fractures and compares the outcomes of different interventions on healing and pain relief.

Methods:

Articles published up to April 2025 were retrieved from PubMed, Embase, and Web of Science. Two authors independently reviewed and extracted data from randomized controlled trials assessing seven types of physical agent modalities: Electrical Stimulation (ES), Pulsed Electromagnetic Fields Stimulation (PEMFS), Ultrasound Therapy (UST), Low-Level Laser Therapy (LLLT), Magnetic Stimulation (MS), Extracorporeal Shock Wave Therapy (ESWT), and Capacitively Coupled Electric Field Stimulation (CCEFS). Standard meta-analysis and network meta-analysis (NMA) were performed for three outcomes: Pain Relief Difference, Time to Complete Fracture Healing (days), and Number of Cases Achieving Complete Fracture Healing. Cumulative ranking curves (SUCRA) scores were calculated for each therapy, with data presented as mean differences (MD) and 95% confidence intervals (CI).

Results:

This meta-analysis includes 39 studies with 2,379 participants. The standard meta-analysis results show that physical agent modalities can markedly enhance fracture healing, with significant pain relief (MD = 1.30, 95% CI: 0.61, 1.99), P = 0.0002, shorter time to complete fracture healing (days) (MD = −21.58, 95% CI: −31.05, −12.11), P < 0.0001, and more number of cases achieving complete fracture healing (RR = 1.37, 95% CI: 1.17, 1.60), P < 0.0001. However, the NMA findings indicate that most direct or indirect comparisons between different physical agent therapies yield pooled effect sizes whose 95% confidence intervals include the null value (0 or 1), showing no significant differences between groups. SUCRA rankings revealed that LLLT (87.5%) and ES (80.8%) were more effective in pain relief, while UST (82.9%) and CCEFS (99.9%) excelled in promoting fracture healing.

Conclusion:

LLLT, ES, UST, and CCEFS may yield improved outcomes for fracture patients; however, further high-quality, large-scale randomized controlled trials are required to validate these findings.

1 Introduction

Bone fractures, a prevalent condition, are currently witnessing an upward trend in global incidence (1), predominantly linked to population ageing and increased life expectancy. According to United Nations research, the global population aged ≥65 years is projected to reach 1.5 billion by 2050 (2, 3). As the ageing process accelerates, the incidence of fractures continues to rise, imposing substantial socioeconomic burdens on individuals, families, and societies (4). Fracture patients often experience major symptoms such as restricted mobility and acute pain (5), which typically ease over a two-month period, with most individuals reaching optimal recovery within 3–6 months (6). Depending on the severity of the fracture, treatment may involve either conservative management or surgery. For non-displaced fractures, conservative treatment generally leads to good outcomes; according to the BMJ Clinical Practice Guidelines1, recovery usually takes 3–4 weeks with relatively rapid pain relief. Displaced fractures, on the other hand, often require surgical intervention, which can support earlier functional recovery (around 10–14 weeks) (7), but may also carry about a 20% risk of non-union and persistent pain, potentially affecting quality of life (811). It is important to note that the duration of pain relief following surgery varies considerably among individuals (12).

Bone healing following a fracture is a complex physiological process that is typically divided into four stages: the fracture and inflammatory phase, the angio-mesenchymal phase, the bone formation phase, and the bone remodeling phase. Although each phase possesses distinct characteristics, they often occur alternately and exhibit a degree of overlap (13). The process of bone healing is influenced by a variety of factors, including the nature and extent of the injury, the damage to the surrounding soft tissues, blood supply, the differentiation capacity of osteoblasts, and the cellular microenvironment as internal factors. Additionally, external factors such as the stability of fracture fixation, the gap between fracture ends, the inflammatory response, and external physical stimuli also play a significant role in the healing process (14). In the final stage of bone healing, known as the bone remodeling phase, approximately 5–10% of long bone fractures may experience non-union (15). In cases of delayed healing or non-union during the fracture healing process, surgical intervention is often required. Autologous bone grafting, regarded as the gold standard for the treatment of fractures and bone defects, has been widely employed in clinical practice (16). In addition to surgical treatment, non-invasive physical agent modalities such as electrical stimulation, electromagnetic stimulation, low-intensity pulsed ultrasound, and low-level laser therapy have been shown to facilitate the acceleration of fracture healing and have gained widespread recognition in clinical practice. These adjunctive therapies provide effective supplementary strategies for optimizing the healing of fractures (1720).

Most randomized controlled trials (RCTs) use standard care as a control, while few directly compare distinct physical agent modalities modalities. Traditional meta-analyses typically allow for the comparison of only two treatment methods at a time, failing to provide comprehensive evidence regarding the relative efficacy of various interventions for fracture healing. Network meta-analysis (NMA) addresses this limitation by facilitating simultaneous comparisons of multiple treatment options and enabling the ranking of each intervention based on various outcomes. This approach offers clinicians a clear, evidence-based framework for treatment decisions, thereby assisting in making informed and scientifically sound clinical choices when addressing complex cases of delayed healing or non-union (21).

Consequently, we conducted a NMA aimed at synthesizing the existing evidence to compare the efficacy of different physical agent modalities in promoting fracture healing and alleviating pain. The specific objective is to identify the most effective physical agent modalities approach, thereby providing robust support for clinical decision-making and assisting in the optimization of treatment strategies for fracture healing.

2 Methods

The protocol was registered with PROSPERO under registration number CRD420251030229.

2.1 Search strategy

This NMA adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (22). As of April 2025, we conducted a comprehensive search for relevant literature in the PubMed, Embase, and Web of Science databases. Search strategies were developed for each of the three databases (See Supplementary Table 1 for details). Two authors (LL and SFH) independently conducted literature searches and screenings, with any discrepancies resolved through mutual discussion. To augment potential relevant studies, the authors also examined the references of the included literature. The language was restricted to English, with no date limitations applied.

2.2 Exclusion and inclusion criteria

Studies that met the following criteria were included: (1) Patients with fractures or delayed healing following a fracture, regardless of fracture location and severity. (2) Physical agent modalities involving one or more of the following: Electrical Stimulation (ES), Pulsed Electromagnetic Fields Stimulation (PEMFS), Ultrasound Therapy (UST), Low-Level Laser Therapy (LLLT), Magnetic Stimulation (MS), Extracorporeal Shock Wave Therapy (ESWT), and Capacitively Coupled Electric Field Stimulation (CCEFS). (3) Control groups receiving either placebo stimulation or standard treatment alone. (4) studies reporting at least one outcome of interest, including pain, time to complete fracture healing, and the number of cases of complete fracture healing. (5) Randomized controlled trial (RCT) design. We excluded: ➀ Non-human studies; ➁ Studies lacking quantifiable outcome measures; ➂ Studies not involving disease models; ➃ Case reports, reviews, editorials, commentaries, conference abstracts, and articles not in English.

2.3 Data extraction

Two authors independently conducted eligibility assessments on the retrieved articles, initially excluding irrelevant studies based on their titles and abstracts. The remaining articles were then downloaded for a comprehensive review of the full texts, from which data were extracted for the eligible studies, including the first author’s name, publication year, country/region, participant characteristics (sample size, mean age, fracture location), interventions, follow-up duration, and outcomes of interest (Table 1). When extracted data were presented as medians and interquartile ranges, we applied Hozo’s formula to convert them into means and standard deviations (23). In cases of discrepancies, discussions were held to reach consensus. If any required information was missing, the corresponding author of the article was contacted via email.

TABLE 1

References Country/
Regions
Mean age (years) (SD)
Intervention/Comparator
Intervention/
Comparator
Sample size (n)
(intervention/comparator)
Intervention/Comparator
Fracture site Follow-up Outcomes
Acosta-Olivo et al. (36) Mexico 54.8 (13.07) Laser acupuncture/acupuncture 13 13 Wrist Bone 1 month Pain relief difference
Barker et al. (37) UK >18 >18 Magnetic field/placebo stimulation 9 7 Tibia 12 month Number of cases achieving complete fracture healing
Beck et al. (38) Australia 28.33 (7.68) 26.09 (7.99) Capacitively coupled electric field/placebo stimulation 22 21 Tibia 2 month Time to complete fracture healing
Busse et al. (39) Canada 37.1 (13.2) 39.1 (14.6) LIPUS/placebo stimulation 214 201 Tibia 1 year + Number of cases achieving complete fracture healing
Chang et al. (40) Taiwan 33.64 (7.82) 30.56 (9.61) Laser/placebo stimulation 25 25 Wrist and Hand 2 week Pain relief difference
Cheing et al. (41) China 63.8 (12.6) 60.3 (20.2) Electromagnetic field/placebo stimulation 23 22 Distal radius 5 day Pain relief difference
Duran et al. (42) Istanbul 58.9 (10.7) 62.0 (9.5) IFC/placebo stimulation 18 17 Proximal humeral 4 month + Pain relief difference
Elboim-Gabyzon et al. (43) Israel 80.26 (9.83) 78.06 (8.45) TENS/placebo stimulation 23 18 Hip 5 day Pain relief difference
Elsebahy et al. (44) Egypt 5 ∼ 8 LIPUS/none 15 15 supracondylar 1 month + Time to complete fracture healing
Factor et al. (45) Israel 58 (13.25) 59 (16.75) Electromagnetic field/placebo stimulation 14 13 Distal radius 3 month Number of cases achieving complete fracture healing;
time to complete fracture healing
Factor et al. (46) Israel 49 59 Electromagnetic field/placebo stimulation 11 14 Distal radius 6 month Number of cases achieving complete fracture healing
Fourie et al. (47) South Africa 35 (11) 31 (13.25) IFC/placebo stimulation 41 35 Tibial shaft 2 years + Time to complete fracture healing
Gopalan et al. (48) India 28 (7.291) 26.75 (8.723) LIPUS/none 20 20 Mandibular 3 month Number of cases achieving complete fracture healing
Gorodetskyi et al. (49) Russia 71.5 (2) 70.8 (3) Non-invasive interactive neurostimulation/placebo stimulation 30 30 Trochanteric of the femur 10 day Pain relief differences
Gorodetskyi et al. (50) Russia 35.3 (9) 38.4 (9) Non-invasive interactive neurostimulation/placebo stimulation 30 30 Ankle 11 day Pain relief difference
Hannemann et al. (51) Netherlands 35 (13) 34 (14.75) Electromagnetic field/placebo stimulation 51 51 Scaphoid 1 year + Time to complete fracture healing
Hannemann et al. (52) Netherlands 44.3 (17) 37.7 (13.25) Electromagnetic field/placebo stimulation 24 29 Scaphoid 1 year + Time to complete fracture healing
Heckman et al. (53) USA 36 (2.3) 31 (1.8) LIPUS/placebo stimulation 33 34 Tibia 9 month + Number of cases achieving complete fracture healing;
time to complete fracture healing
Kristiansen et al. (54) USA 54 (3) 28 (2) LIPUS/placebo stimulation 30 31 Distal radial 3 month + Number of cases achieving complete fracture healing;
time to complete fracture healing
Liu et al. (55) China 61.5 (2.1) 63.5 (1.2) Electromagnetic field/placebo stimulation 40 42 Vertebral 3 month + Pain relief difference
Liu et al. (56) China 67.9 (5.58) 65.7 (6.09) LIPUS/none 41 40 Distal radius 1 month + Time to complete fracture healing
Martinez-Rondanelli et al. (57) Colombia 31 (10) 29 (9) Electromagnetic field/placebo stimulation 32 31 Diaphyseal femoral 6 month Number of cases achieving complete fracture healing
Mohajerani et al. (58) Iran 37.06 (10.6) 37 (10.7) Electromagnetic field/none 16 16 Mandibular 2 week Pain relief difference
Moncada et al. (59) Colombia 30.2 Magnetic field/placebo stimulation 32 32 Femoral shaft 6 month Number of cases achieving complete fracture healing
Oncel et al. (60) Turke 44 (15) 40 (16) TENS/placebo stimulation 25 25 rib 3 day Pain relief difference
Patel et al. (61) India 15 ∼ 35 LIPUS/none 14 14 Mandibular 1 month + Pain relief difference
Piazzolla et al. (62) Italy 73.6 (7.82) 72.88 (6.09) Capacitively coupled electric field/none 33 33 Vertebral 6 month Pain relief difference
Ricardo et al. (63) Cuba 26.7 LIPUS/placebo stimulation 10 11 Scaphoid 2.3 years Time to complete fracture healing
Santana-Rodríguez et al. (64) Saudi Arabia 64 (13.1) 58.9 (17.3) PUS/placebo stimulation 24 23 Rib 6 month Pain relief difference
Schofer et al. (65) Germany 42.6 (14.6) 45.1 (11.9) LIPUS/placebo stimulation 51 50 Tibia 4 month Number of cases achieving complete fracture healing
Scott et al. (66) UK 40 (9.05) 46 (20.09) Capacitively coupled electric field/placebo stimulation 10 11 Long bones 9 month Number of cases achieving complete fracture healing
Sharrard et al. (67) UK 34.7 (17.66) 45.4 (14.76) Electromagnetic field/placebo stimulation 20 25 Tibia 3 month Number of cases achieving complete fracture healing
Shi et al. (68) China 41.1 (14.5) 38.4 (11.6) Electromagnetic field/placebo stimulation 31 27 Long bones 4 month + Number of cases achieving complete fracture healing
Simonis et al. (69) UK 31.7 (14.6) 32.3 (16.3) Electrical stimulation/placebo stimulation 18 16 Tibia 6 month Number of cases achieving complete fracture healing
Streit et al. (70) USA 47 (9.75) Electrical stimulation/placebo stimulation 5 3 Metatarsal 5 month + Time to complete fracture healing
Wang et al. (71) Taiwan 35.5 (16.0) 35.4 (19.2) Shock wave/none 27 30 Long bones 12 month Pain relief difference;
number of cases achieving complete fracture healing
White et al. (72) Canada 27.1 (9.4) 26.5 (12.1) LIPUS/placebo stimulation 69 73 Scaphoid 2.4 years Number of cases achieving complete fracture healing
Wu et al. (73) China 43.1 (9.6) 42.5 (8.2) ST + PNF + TEAS/ST + PNF 20 20 Tibial plateau 1 month + Pain relief difference
Yadav et al. (74) India Unclear Unclear Ultrasound/placebo stimulation 39 28 Tibia 1 month + Number of cases achieving complete fracture healing

Main characteristics of included studies.

2.4 Risk of bias

The risk of bias in the included studies was assessed using the Cochrane Risk of Bias Tool (RoB 2.0)2 (24) across six domains: the randomization process, deviations from intended interventions, missing outcome data, measurement of the outcome, selection of the reported results, and other sources of bias. The two authors independently rated each study as “low risk,” “high risk,” or “some concerns” for each of the aforementioned domains. Any discrepancies that arose during the review process were resolved through discussion or negotiation between the two authors.

2.5 Statistical analysis

In this study, for dichotomous outcomes, we reported risk ratios (RR) with 95% credible intervals, while for continuous outcome variables, we reported mean differences (MD) with 95% confidence intervals (CIs). Traditional meta-subgroup analyses were conducted using Review Manager 5.4.1, while calculations and visualizations were carried out using R 4.4.3 (R Foundation for Statistical Computing) and Stata SE 15.1 (StataCorp, College Station, TX). Given the heterogeneity between trials, we employed a Bayesian hierarchical random effects model for multiple comparisons (25, 26). Based on the theory of the likelihood function and certain initial assumptions, we performed Markov Chain Monte Carlo (MCMC) simulations using R 4.4.3, with 500,000 iterations and 20,000 for annealing to investigate posterior distributions (2729). We assessed model goodness-of-fit by calculating the deviance information criterion (DIC) and employed the node splitting method to compare the consistency of direct and indirect evidence for each comparison (30). To address heterogeneity in the study, a random effects model was employed, and the degree of heterogeneity was quantified using the I2 statistic. To rank the interventions, we calculated the Surface Under the Cumulative Ranking Curve (SUCRA) probability values, which range from 0 to 1, with higher values indicating that the intervention is more likely to be the most effective (31, 32). A network diagram was created to analyse the geometrical structure of the intervention network and to identify potential biases, with the size of the nodes representing the number of participants in each group and the thickness of the lines reflecting the number of studies. A conjugate prior distribution was used for the Bayesian network meta-analysis (NMA), and a ranking table was generated to illustrate the comparisons of each pair of interventions for each outcome. Pairwise meta-analyses were conducted using the DerSimonian-Laird random effects model to estimate the variance of heterogeneity and obtain direct evidence (33). Finally, we utilized a comparison-adjusted funnel plot to assess potential publication bias (34, 35). Furthermore, sensitivity analyses were performed to explore their potential impact on the conclusions.

3 Results

3.1 Description of the included studies

We searched the PubMed, Embase, and Web of Science databases, identifying 341, 797, and 404 articles, respectively. After removing 410 duplicate articles, a total of 1,132 articles were identified. Based on title and abstract screening, 1,042 articles were excluded, leaving 90 articles that underwent full-text review, of which 39 articles met the eligibility criteria for our systematic review and NMA (3674). The detailed PRISMA flow chart is presented in Figure 1.

FIGURE 1

Flowchart illustrating the identification and screening of studies for review. Initially, 1,542 records were identified from PubMed, Embase, and Web of Science. After removing 410 duplicates, 1,132 records were screened. 1,042 were excluded based on abstracts and article types. Out of 90 full texts sought for retrieval, 50 were assessed for eligibility. Full texts were excluded for reasons such as language and relevance, resulting in 39 studies included in the review.

Flow diagram of the preferred reporting items for systematic reviews and meta-analyses (PRISMA) criteria. RCTs, randomized controlled trials.

Table 1 summarizes the characteristics of the 39 studies. Among these, 15 studies assessed pain improvement before and after physical agent modalities, 13 studies reported the time to complete fracture healing, and 17 studies documented the number of patients with fully healed fractures. Three studies evaluated capacitively coupled electric field stimulation, nine studies assessed electrical stimulation (ES), two studies investigated magnetic stimulation (MS), ten studies examined pulsed electromagnetic field stimulation (PEMFS), two studies focused on low-level laser therapy (LLLT), one study assessed extracorporeal shockwave therapy (ESWT), and twelve studies investigated ultrasound therapy (UST). This research was conducted across multiple countries, including China, the United States, Russia, Israel, Colombia, and India, and included 2,379 participants, with ages ranging from 5 to 72 years. The fracture sites were diverse, comprising 2.90% for humeral fractures (reported in two articles), 8.34% for femoral fractures (reported in three articles), 2.67% for ankle fractures (reported in one article), 14.18% for scapular fractures (reported in four articles), 10.66% for radial fractures (reported in five articles), 40.30% for tibial fractures (reported in ten articles), 1.82% for hip fractures (reported in one article), 4.32% for rib fractures (reported in two articles), 2.23% for carpal fractures (reported in two articles), 4.46% for mandibular fractures (reported in three articles), 0.4% for metatarsal fractures (reported in one article), and 6.60% for vertebral fractures (reported in two articles). Additionally, three studies reported on long bone fractures involving a total of 136 participants. Finally, the follow-up durations for the three outcome measures varied: the pain relief difference ranged from 5 days to 6 months; the time to complete fracture healing ranged from 1 month to 2.3 years; and the number of cases achieving complete fracture healing ranged from 1 month to 2.4 years.

3.2 Risk of bias

We conducted an assessment of the risk of bias, the results of which are illustrated in Figure 2. Among the studies, 26 indicated a low risk of bias, 11 reported a moderate risk, and 2 demonstrated a high risk. All studies reported randomization. However, J. D. Heckman et al. (53), M. Oncel et al. (60) and G. Scott et al. (66) conducted unplanned treatments during the intervention phase, leading to their classification as moderate risk. W. J. Sharrard et al. (67) and N. J. White et al. (72) were deemed high risk due to individual participants withdrawing from the trial as a result of the intervention. Furthermore, B. R. Beck et al. (38), J. W. Busse et al. (39), E. Duran et al. (42), A. Piazzolla et al. (62), N. Santana-Rodríguez et al. (64) and H. F. Shi et al. (68) were classified as moderate risk due to dropout or loss to follow-up for personal reasons, whereas all other studies reported no loss of outcome data. B. R. Beck et al. (38) was also rated as moderate risk for failing to assess whether fractures had fully healed based on imaging reports; all other studies were classified as low risk. Additionally, all studies, except for S. Y. Elsebahy et al. (44) and M. E. Moncada et al. (59), did not show any potential risk of selective reporting bias.

FIGURE 2

Risk of bias table for various studies. Columns include randomization process, deviations from interventions, missing outcome data, outcome measurement, result selection, and overall risk. Green circles indicate low risk, yellow circles indicate some concerns, and red circles indicate high risk. Categories are listed for studies by different authors and years.

Traffic light plot for the risk-of-bias assessment of included trials.

3.3 Standard meta-analysis

3.3.1 Pain relief difference

This study included 14 investigations that assessed pain intensity using the Visual Analogue Scale (VAS). To illustrate the extent of pain relief, we used the difference between the VAS score recorded before the application of physical agent modalities and the score obtained after the final treatment session as the primary analytical measure. Due to significant overall heterogeneity (I2 = 90.8%, P < 0.00001), a random-effects model was employed for the meta-analysis of pain scores. The analyses were further divided into six subgroups based on different physical interventions (LLLT, CCEFS, UST, ESWT, ES, PEMFS) (Figure 3A). For ES, I2 was found to be 92% (P < 0.00001), while LLLT and PEMFS reported I2 values of 0% and 4%, respectively. Due to the limited number of studies, I2 could not be calculated for the remaining three interventions. Hence, the variation in different physical agent modalities may have contributed to the high heterogeneity observed. The analysis results demonstrated that LLLT significantly reduced pain in fracture patients: MD = 2.22, 95% CI (1.50, 2.94), P < 0.00001. This was followed by ES: MD = 1.86, 95% CI (0.90, 2.82), P = 0.0002; UST: MD = 1.30, 95% CI (0.39, 2.21), P = 0.005; PEMFS: MD = 0.52, 95% CI (0.24, 0.81), P = 0.0003; ESWT: MD = 0.52, 95% CI (0.16, 0.88), P = 0.004. Lastly, CCEFS showed an MD of −0.56, 95% CI (−1.01, −1.11), P = 0.01, indicating that CCEFS did not alleviate pain, this may be largely attributed to two factors: First, the number of studies included in the analysis was limited, with only one investigation evaluating the analgesic effect of CCEFS, resulting in insufficient statistical power. Second, that study adopted a follow-up period of up to 6 months; although pain levels showed marked improvement over time, the dominant role of the body’s own repair mechanisms during the natural fracture healing process may have substantially diluted the additional effects of physical agent therapy in the later stages. This could be a key reason for the negative effect observed. Future high-quality studies with shorter follow-up periods, particularly during the acute phase, are recommended to clarify the true effectiveness of CCEFS in pain management. In the sensitivity analysis, excluding individual studies did not lead to significant changes in the overall results, suggesting that the findings are robust (Supplementary Figure 1A).

FIGURE 3

Forest plots labeled A, B, and C depict the results of multiple studies. Each panel lists study subgroups with experimental and control data, illustrating mean differences and risk ratios with confidence intervals and weights. Diamonds and lines represent the effect size and confidence intervals for each study and overall. Heterogeneity statistics such as I2 and Chi-square are included. Panel A focuses on different therapies; B includes coupled electric field and electromagnetic fields; C covers magnetic stimulation and shock wave therapy. Each chart emphasizes overall effects and subgroup analyses.

Forest plot of comparison: physical agent modalities group versus control group. (A) Difference between post-treatment and pre-treatment pain scores; (B) time to complete fracture healing (days); (C) number of patients with fully healed fractures.CI, confidence interval; MD, mean difference.

3.3.2 Time to complete fracture healing (days)

In total, 9 studies were included, reporting on the fracture healing times of patients with different fracture locations following physical agent modalities. Due to the high overall heterogeneity of the included studies (I2 = 82.7%, P = 0.0006), a random-effects model was employed for the meta-analysis. Furthermore, subgroup analyses were conducted for different physical agent modalities (CCEFS, ES, PEMFS, UST) (Figure 3B). The I2 values for PEMFS and UST were 29% and 99%, respectively, while I2 could not be calculated for CCEFS and ES due to an insufficient number of studies. Thus, the high heterogeneity may be attributed to the different physical intervention methods employed. The results indicated that the treatment group showed a significant improvement in fracture healing time compared to the control group, UST: MD = −28.09, 95% CI (−40.27, −15.91), P < 0.00001; PEMFS: MD = −11.26, 95% CI (−22.39, −0.13), P = 0.05; CCEFS: MD = 3.10, 95% CI (−5.67, 11.87), P = 0.49; ES: MD = −19.49, 95% CI (−51.23, 12.25), P = 0.23. Although CCEFS and ES did not show statistical significance, the overall results indicated that physical agent modalities effectively reduced fracture healing time: MD = −21.58, 95% CI (−31.05, −12.11), P < 0.00001. In the sensitivity analysis, the summary results remained stable after the exclusion of individual studies, suggesting that the findings are robust (Supplementary Figure 1B).

3.3.3 Number of cases achieving complete fracture healing

16 included studies reported on the number of cases achieving complete fracture healing. Due to moderately high overall heterogeneity (I2 = 46.9%, P = 0.09), a random-effects model was still employed. The results indicated that, overall, physical agent modalities significantly increased the number of cases achieving complete fracture healing compared to the control group, with a risk ratio (RR) of 1.37, 95% confidence interval (CI) (1.17, 1.60), P < 0.0001. Further subgroup analyses were conducted based on different physical agent modalities (MS, CCEFS, PEMFS, ES, ESWT, UST) (Figure 3C), revealing that PEMFS and UST exhibited statistically significant effects and played a positive role in promoting fracture healing, PEMFS: RR = 1.92, 95% CI (1.01, 3.65), P = 0.05; UST: RR = 1.44, 95% CI (1.13, 1.84), P = 0.003. In addition, the I2 values for MS, PEMFS, and UST were 6%, 75%, and 77%, respectively, indicating that the high heterogeneity may still be attributed to the different physical intervention methods. In the sensitivity analysis, after excluding individual studies, the summary results did not show significant changes, suggesting that the findings are robust (Supplementary Figure 1C).

3.4 Network meta-analysis

3.4.1 Network map

We generated three network node diagrams (Figures 4A–C), three primary outcomes, each involving different physical agent modalities. Analysing these study data, we assessed the relative efficacy of seven types of physical agent modalities (Figures 4D–F). Further details are provided in the ranking table (Supplementary Table 2). We conducted pairwise comparative analyses of all treatment approaches using MD and RR with 95% confidence intervals. The results showed that, for most comparisons between physical agent modalities, the 95% confidence intervals included the null value (MD = 0 or RR = 1), indicating that the differences in effectiveness between these interventions did not reach statistical significance. This suggests that the relative efficacy of different physical agent modalities remains uncertain. However, a trend suggesting that Low-Level Laser Therapy (LLLT) may be more effective in alleviating post-fracture pain compared with the other five groups. The following data supports this assertion: ESWT vs LLLT: MD = −1.74, 95% CI (−3.94, 0.45); CCEFS vs LLLT: MD = −2.82, 95% CI (−5.03, –0.61); PEMFS vs LLLT: MD = −1.68, 95% CI (−3.41, 0.04); UST vs LLLT: MD = −0.96, 95% CI (−3.31, 1.39), and ES vs LLLT: MD = −0.37, 95% CI (−1.97, 1.22) (Figure 4D). Similarly, when considering the time to complete fracture healing (days), although no statistically significant differences were observed, UST showed a notable trend toward reducing the time to complete fracture healing (days) compared to the other groups. This trend is supported by the data: UST vs CCEFS: MD = −31.22, 95% CI (−69.42, 6.97); UST vs PEMFS: MD = −12.36, 95% CI (−38.40, 13.69); ES vs UST: MD = 8.63, 95% CI (−40.25, 57.51) (Figure 4E). Moreover, when considering the number of patients achieving complete fracture healing, CCEFS demonstrated a significant advantage over the other intervention groups, CCEFS vs MS: RR = 13.79, 95% CI(0.78, 244.89); CCEFS vs ESWT: RR = 12.61, 95% CI (0.70, 228.37); PEMFS vs CCEFS: RR = 0.12, 95% CI (0.01, 2.03); UST vs CCEFS: RR = 0.10, 95% CI (0.01, 1.80); ES vs CCEFS: RR = 0.13, 95% CI (0.01, 2.36) (Figure 4F).

FIGURE 4

“Three network diagrams and three forest plots compare different treatment effects. Panel A shows treatments like electromagnetic, electrical, laser, and others with placebo as the central node. Panel B has electromagnetic, electrical, and capacitive coupling. Panel C includes magnetic, electromagnetic, electrical, and others. Panels D, E, and F present forest plots of treatment effects with confidence intervals, showing comparisons between placebo and other treatments across different metrics. Each plot includes a vertical line marking zero for reference.”

Network meta-analysis of physical agent modalities for fractures. (A–C) Network evidence plots for fractures. (D–F) Forest plot represents the direct and indirect comparison. PL, placebo; LLLT, low-level laser therapy; MS, magnetic stimulation; ESWT, extracorporeal shock wave therapy; CCEFS, capacitively coupled electric field stimulation; PEMFS, pulsed electromagnetic fields stimulation; UST, ultrasound therapy; ES, electrical stimulation.

3.4.2 Ranking of treatments

Figure 5 illustrates the cumulative probabilities of each intervention across various potential rankings, represented by SUCRA values, which indicate the ranking of treatments; a higher SUCRA value signifies a more favorable ranking among all available treatments. A SUCRA value of 100% denotes the best treatment effect, while a SUCRA value of 0% indicates the poorest treatment effect. According to the ranking results shown in Table 2, the two highest-ranked interventions for pain relief are LLLT (SUCRA 87.5%) and ES (SUCRA 80.8%), followed by UST (SUCRA 62.5%), PEMFS (SUCRA 42.9%), ESWT (SUCRA 41.0%), and CCEFS (SUCRA 13.7%). In terms of time to complete fracture healing (days), UST (SUCRA 82.9%) and ES (SUCRA 61.3%) are ranked highest, followed by PEMFS (SUCRA 58.7%) and CCEFS (SUCRA 24.7%). Finally, with respect to the number of patients achieving complete fracture healing, CCEFS (SUCRA 99.9%) and PEMFS (SUCRA 67.6%) ranked highest, followed by ES (SUCRA 58.4%), UST (SUCRA 53.6%), ESWT (SUCRA 30.2%), and MS (SUCRA 23.2%).

FIGURE 5

Three rankograms comparing different treatments. (A) Rankogram for pain, showing lines for capacitive coupling, electrical, electromagnetic, laser, shock wave, placebo, and ultrasound. (B) Rankogram for bone healing rate, showing capacitive coupling, electrical, electromagnetic, placebo, and ultrasound. (C) Similar to (B), with the addition of magnetic and shock wave treatments. Each graph plots rank probability against rank.

Rankogram for all outcomes. Each line segment represents a treatment. The area enclosed by the line segment and the coordinate axis represents the cumulative probability of treatment. (A) Difference between post-treatment and pre-treatment pain scores; (B) time to complete fracture healing (days); (C) number of patients with fully healed fractures.

TABLE 2

Physical agent modalities Pain relief difference Time to complete fracture healing (days) Number of cases achieving complete fracture healing
Capacitive_coupling 13.7% 24.7% 99.90%
Electrical 80.8% 61.3% 58.40%
Electromagnetic 42.9% 58.7% 67.60%
Laser 87.5%
Placebo 21.7% 22.4% 17.10%
Shock_wave 41.0% 30.20%
Ultrasound 62.5% 82.9% 53.60%
magnetic 23.20%

SUCRA ranking of different outcome indicators.

3.5 Publication of bias

Funnel plots were employed to assess publication bias for all outcome indicators. The funnel plots for Pain Relief Difference, Time to Complete Fracture Healing (days), and Number of Cases Achieving Complete Fracture Healing exhibited a symmetrical and even distribution, suggesting the absence of significant publication bias (Figure 6).

FIGURE 6

“Three funnel plots are displayed. Plot A shows effect size against the standard error, with scattered colored points and a downward sloping line. Plot B has effect size ranging from negative fifty to positive fifty, with points unevenly distributed and some outliers. Plot C depicts a symmetrical distribution of points around the center line, indicating less bias. Each plot has a legend mapping colors to comparisons.”

Funnel diagram. Publication bias for assessing study results. (A) Difference between post-treatment and pre-treatment pain scores; (B) time to complete fracture healing (days); (C) number of patients with fully healed fractures.

4 Discussion

To the best of our knowledge, this study represents the first NMA comparing the efficacy of different physical agent modalities for treating patients with fractures. This NMA meticulously reviewed the most recent data from 39 eligible randomized controlled trials, evaluating the effectiveness of physical agent modalities in fracture patients. This study confirms that physical agent modalities significantly promotes fracture healing and alleviates pain. To compare the effects of different physical agent modalities, we sought indirect evidence through pairwise comparisons. However, indirect treatment comparisons revealed no statistically significant differences in efficacy among the seven modalities. Subsequently, by calculating the SUCRA values for these therapies and conducting a ranking analysis, we found that both LLLT and ES significantly relieve pain, with the reduction in pain scores likely reaching or even exceeding the minimal clinically important difference. This indicates that their effects go beyond statistical significance and provide pain relief that is genuinely meaningful to patients. Such a degree of improvement can help enhance sleep quality and daily functioning, thereby improving overall quality of life and potentially reducing dependence on analgesic medications. Consequently, these two physical agent modalities demonstrate substantial clinical value as complementary approaches to pain management. UST markedly shortens fracture healing time, while CCEFS significantly increases the healing rate in patients with fractures, followed by PEMFS. These effects enable patients to regain physical function earlier, fundamentally reducing the risk of complications associated with prolonged immobilization or delayed healing, and ultimately leading to substantial savings in healthcare resources. In this context, these physical agent modalities serve not only as effective clinical tools for preventing fracture non-union but also as strategies that enhance the overall quality of treatment. They therefore provide strong evidence supporting the clinical prioritization of efficient physical therapy modalities. However, since only a few studies have examined the application of LLLT and CCEFS in patients with fractures, this result warrants cautious interpretation.

Patients with fractures often experience acute postoperative pain, which is typically managed with analgesic medications. However, such treatments frequently come with adverse side effects, including nausea, vomiting, delirium, constipation, and gastrointestinal dysfunction. The incidence of these side effects is particularly higher in the elderly population (75), and postoperative analgesic efficacy is often poorer compared to younger individuals (76). Consequently, the application of non-pharmacological and non-invasive analgesic methods in the management of acute postoperative pain has garnered increasing attention. Our research found that low-level laser therapy (LLLT) exhibits the best analgesic effects. However, due to the low certainty of evidence, further studies are required to validate this conclusion. LLLT is based on a specialized technical device capable of emitting light beams with precise characteristics for medical applications. It stimulates the mitochondria to produce ATP, enhances mitochondrial electron transport rates, regulates reactive oxygen species to reduce oxidative stress, and induces the activation of transcription factors such as AP-1, p53, NF-kB, and HIF, thereby promoting extracellular matrix deposition and activating anti-inflammatory and anti-apoptotic pathways. Clinically, these effects manifest as pain and inflammation relief, as well as facilitation of tissue repair (7779). Literature indicates that in vitro, LLLT modulates the inflammatory response by activating the WNT pathway and inhibiting the NF-kB signaling pathway (80). In vivo, it regulates the levels of inflammatory precursor factors such as IL-1, IL-6, IL-8, and IL-18 to control the inflammatory response (81). Furthermore, LLLT positively influences bone tissue metabolism and fracture healing (82, 83) by stimulating microcirculation and increasing the activity of osteoblasts, thus enhancing the osteogenic effect (84). However, therapeutic benefits appear restricted to early healing phases (< 21 days post-fracture), with diminished efficacy in chronic non-union models.(85).

Beyond LLLT, electrical stimulation (ES) encompasses established analgesic approaches such as transcutaneous electrical nerve stimulation (TENS), non-invasive interactive neurostimulation (NIN), and interferential current (IFC). TENS delivers pulsed electrical currents transcutaneously, making it a prevalent non-pharmacological intervention for pain management (86, 87). It is capable of generating a sensation similar to acupuncture at frequencies of 2–4 Hz by stimulating Aδ and C fibers in the afferent nerves, thereby activating downstream pain inhibition pathways and producing a spatially diffuse analgesic effect (88). Studies by Gorodetskyi I et al. (49) and Lord SR et al. (89) have investigated the role of TENS in reducing acute postoperative pain in elderly patients following hip fractures, both reporting significant pain relief, which is consistent with our findings. Moreover, NIN has been shown to have a positive effect in the postoperative care of patients with femoral neck fractures (49), with its pain relief mechanism thought to involve segmental and descending neural inhibition (90). IFC operates on the principle of a low-frequency-modulated medium-frequency current created by the superposition of two medium-frequency currents with slight phase differences (91). IFC therapy is believed to alleviate pain through gate control mechanisms and the release of endogenous opioids (92). Although this therapy has been in use for decades, its physiological effects have not been fully substantiated, making it challenging to completely elucidate its analgesic action (93).

Fracture patients frequently endure acute postoperative pain, conventionally managed with analgesics. However, these pharmacological interventions often induce adverse effects such as nausea, constipation, delirium, and gastrointestinal dysfunction. According to our study, physical agent modalities significantly shortens the time to fracture healing and improves the complete healing rate in fracture patients. SUCRA ranking in this study indicates that ultrasound therapy (UST) can markedly reduce the time to complete fracture healing (days) compared to other physical agent modalities, which aligns with the findings of Kristiansen et al. (54) who reported that treatment with low-intensity pulsed ultrasound (LIPUS) shortened radiological healing times by 38%. When ultrasound propagates through biological tissues, it generates micro-mechanical strain, which stimulates biochemical responses at the cellular level and promotes bone formation (94). Fracture patients often experience prolonged immobilization, leading to a deficiency of mechanical load at the injury site. However, ultrasound can produce mechanical forces that improve the mechanical environment of the affected area, potentially facilitating endochondral ossification, a key mechanism in fracture healing (95, 96). Additionally, the mechanical stress generated by ultrasound further promotes osteogenesis, protein synthesis, calcium uptake, and DNA synthesis in various cell types (97). As ultrasound transmits through the tissue to the bone, cells adjacent to the fracture site convert biomechanical stimuli into biochemical responses via integrins, which serve as crucial molecular mediators of mechanotransduction (98). Furthermore, ultrasound stimulation increases the expression of integrins, enhancing the adhesion of osteoblasts at the fracture site, thereby aiding in fracture healing (99, 100).

Early clinical studies suggest that high-intensity ultrasound stimulation in the range of 5000 to 25000 mW/cm2 may induce adverse effects including necrosis, cessation of bone healing, and fibrous tissue formation (101, 102). Consequently, low-intensity pulsed ultrasound (LIPUS) has consequently become the clinical standard (103). LIPUS has been shown to positively influence fracture healing regardless of the patient’s age, smoking status, the presence of a fracture gap, fibular fractures, or the location of distal fractures (104). Animal studies indicate that LIPUS not only accelerates the formation of bone callus but also enhances the mechanical strength at the fracture site (105, 106). During the fracture healing process, The periosteum serves as a primary reservoir for osteoprogenitor cells during bone regeneration, playing a central role in callus formation. Tam et al. (107) demonstrated that LIPUS interventions positively stimulate osteogenesis and the activation of cell differentiation in human periosteal cells. Additionally, cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) are key biological processes involved in the mineralization and remodeling phases of bone healing (108), COX-2 promotes fracture healing by upregulating genes associated with endochondral ossification and angiogenesis (98, 109), whereas PGE2 enhances collagen synthesis in cultured bone and further stimulates osteoblast proliferation (110). Tang et al. (99) and Kokubu T et al. (111) found that expression of COX-2 and PGE2 in osteoblasts was significantly increased when cells were subjected to ultrasound stimulation.

Pulsed Electromagnetic Fields Stimulation (PEMFS) has emerged as a clinical mainstay (2), demonstrating particular efficacy during the angiogenic-osteogenic coupling phase of bone repair and remodeling (112). Multiple studies have demonstrated that PEMFS actively promotes bone healing by regulating voltage-gated ion channels, increasing cytosolic calcium ion concentrations, enhancing early angiogenesis, and facilitating the differentiation and maturation of osteoblasts (113). Research indicates that PEMFS upregulates TGF-β expression and promotes the proliferation and osteogenic differentiation of stem cells via coordinated signaling through BMP, ERK/MAPK, and Notch pathways (114117). The effectiveness of PEMFS is closely related to exposure duration, to significantly enhance fracture healing, PEMFS should be applied for at least 8 h per day over a period of 45–60 days (118). Furthermore, studies have found that PEMFS can upregulate the expression of placental growth factor (PIGF) and brain-derived neurotrophic factor (BDNF). PIGF, a member of the vascular endothelial growth factor (VEGF) subfamily, is a key regulator of angiogenesis and vasculogenesis (119). BDNF promotes angiogenesis through two mechanisms: Firstly, by locally activating subsets of endothelial cells, and secondly, by recruiting bone marrow-derived cells. These both mechanisms contribute to the formation of new blood vessels, thereby facilitating bone formation (120). Additionally, Parhampour et al. (121) discovered that PEMFS can improve bone metabolic disorders and restore joint function.

In our study, CCEFS demonstrated significant effects on fracture healing and was ranked first in the third outcome measure based on the SUCRA rankings. As a non-invasive bone growth stimulation method, CCEFS has the potential to enhance osteoblast function and increase new bone formation (122). An in vitro study revealed the mechanism of action of CCEFS, which involves the activation of voltage-gated calcium channels in the plasma membrane, leading to increased cytosolic calcium concentration and phospholipase A2 (PLA2) activity (123). The rise in cytosolic calcium activates the calmodulin pathway, further upregulating the expression of osteogenic-related genes, including fibroblast growth factor (FGF) 2, osteocalcin (OCN), TGF-β, BMP, and alkaline phosphatase (ALP) (124, 125). PLA2 promotes the synthesis of PGE2, thereby further facilitating the osteogenic process (126). Additionally, a study (127) have reported that CCEFS has a positive impact on alleviating chronic pain. However, our NMA did not demonstrate a significant effect of CCEFS on post-fracture pain relief. This may be attributed to the inclusion of only one relevant study (62), which, although indicating that CCEFS could more rapidly relieve pain, found no significant difference in the overall level of pain relief compared to the control group.

In the included studies, the number of investigations on LLLT, MS, ESWT, and CCEFS was relatively limited, largely reflecting the characteristics of each technique and their current clinical use. ESWT carries a potential risk of secondary injury due to possible adverse effects such as hematoma formation and increased pain (128). Research on MS has focused mainly on neurological rehabilitation (129), with comparatively less application in fracture treatment. CCEFS already has a well-established therapeutic protocol for fracture healing (122), and its technical stability has resulted in fewer novel research directions. For LLLT, progress in fracture pain management has been slow, partly due to the lack of standardization in pain assessment tools (such as VAS, NRS, and the McGill Pain Questionnaire) and partly because current clinical practice still relies heavily on pharmacological analgesia (130). These factors may together contribute to the current relative scarcity of research on these therapies in the field of fracture rehabilitation.

5 Limitation

First, restricted study availability and underpowered sample sizes compromised generalizability while reducing statistical precision. Second, there was an imbalance in the number of comparisons and sample sizes among the physical agent modalities. Among the three different outcome measures, studies on UST constituted the largest proportion, while those on CCEFS and MS comprised the smallest, which may have impacted the research findings. Third, we acknowledge the substantial heterogeneity observed in this study, which may largely stem from clinical differences among the included trials, such as variations in fracture type, duration of intervention, and device parameters. Because the original studies provided insufficient data, we were unable to perform subgroup analyses to further explore the specific influence of these factors. Therefore, the findings of this network meta-analysis should be interpreted as representing an overall effect across diverse clinical contexts. Future studies should adopt more standardized designs and provide more detailed reporting to better account for these key variables. Fourth, the lack of direct comparisons between physical agent modalities, relying instead on indirect evidence, may limit the reliability and comprehensiveness of the conclusions. Finally, the use of SUCRA scores does not account for differences in study quality and relies solely on relative ranking to evaluate treatment efficacy. Including low-quality studies may introduce bias and lead to systematic errors in effect size estimation. When such biased estimates are incorporated into a network meta-analysis model, they can distort the true comparative effectiveness between treatments, causing the SUCRA rankings to deviate from reality and reducing their overall reliability. Given that the design of the SUCRA scoring system focuses on relative efficacy while neglecting effect size, it may inadvertently undermine the clinical significance of the treatment effects.

6 Conclusion

Physical agent modalities demonstrate therapeutic potential in fracture management, effectively reducing pain and enhancing osseous regeneration. In indirect head-to-head comparisons, although different physical agent modalities did not show clear advantages or disadvantages in pain relief and fracture healing, this study provides valuable insights for clinical decision-making. Notably, LLLT and ES displayed potential advantages in pain alleviation, while UST and CCEFS exhibited superior effectiveness in promoting fracture healing. However, these preliminary conclusions require validation through high-quality, large-sample randomized controlled trials, and further clinical research is necessary to confirm the efficacy of these interventions.

Statements

Data availability statement

The original contributions presented in this study are included in this article/Supplementary material, further inquiries can be directed to the corresponding authors.

Author contributions

LL: Writing – original draft, Visualization, Writing – review & editing, Formal analysis, Conceptualization. LY: Formal analysis, Writing – original draft, Writing – review & editing, Conceptualization, Visualization. YY: Writing – original draft, Writing – review & editing. JZ: Software, Writing – review & editing, Data curation, Methodology. RS: Validation, Methodology, Writing – review & editing, Data curation. QD: Data curation, Writing – review & editing, Validation, Methodology. JW: Software, Data curation, Validation, Writing – review & editing. FS: Writing – review & editing, Funding acquisition.

Funding

The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by the fund of Southwest Medical University under Grant 2023ZD003, and the Luzhou City Science and Technology Bureau under Grant 2020LZXNYDJ44.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The authors declare that no Generative AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmed.2025.1646903/full#supplementary-material

Abbreviations

RCTs, randomized controlled trials; NMA, network meta-analysis; ES, electrical stimulation; PEMFS, pulsed electromagnetic fields stimulation; UST, ultrasound therapy; LLLT, low-level Laser therapy; MS, magnetic stimulation; ESWT, extracorporeal shock wave therapy; CCEFS, capacitively coupled electric field stimulation; TENS, transcutaneous electrical nerve stimulation; NIN, non-invasive interactive neurostimulation; LIPUS, low-intensity pulsed ultrasound; RR, risk ratios; MD, mean differences; CIs, confidence intervals; MCMC, Markov Chain Monte Carlo; DIC, deviance information criterion; SUCRA, surface under the cumulative ranking curve; COX-2, cyclooxygenase-2; PGE2, prostaglandin E2; PIGF, placental growth factor; BDNF, brain-derived neurotrophic factor; VEGF, vascular endothelial growth factor; PLA2, phospholipase A2; FGF, fibroblast growth factor; OCN, osteocalcin; ALP, alkaline phosphatase.

References

  • 1.

    Wu J Che Y Zhang Y Wang J Chen M Jiang J et al Global, regional, national trends of femur fracture and machine learning prediction: comprehensive findings and questions from global burden of disease 1990-2019. J Orthop Translat. (2024) 46:4652. 10.1016/j.jot.2024.03.002

  • 2.

    Massari L Benazzo F Falez F Perugia D Pietrogrande L Setti S et al Biophysical stimulation of bone and cartilage: state of the art and future perspectives. Int Orthop. (2019) 43:53951. 10.1007/s00264-018-4274-3

  • 3.

    Vasconcelos PAB Rocha AJ Fonseca RJS Teixeira TRG Mattos ESR Guedes A . Femoral fractures in the elderly in Brasil - incidence, lethality, and costs (2008-2018).Rev Assoc Med Bras. (2020) 66:17026. 10.1590/1806-9282.66.12.1702

  • 4.

    Cauley JA . The global burden of fractures.Lancet Healthy Longev. (2021) 2:e5356. 10.1016/s2666-7568(21)00183-5

  • 5.

    Platts-Mills TF Flannigan SA Bortsov AV Smith S Domeier RM Swor RA et al Persistent pain among older adults discharged home from the emergency department after motor vehicle crash: a prospective cohort study. Ann Emerg Med. (2016) 67:16676.e1. 10.1016/j.annemergmed.2015.05.003

  • 6.

    MacDermid JC Roth JH Richards RS . Pain and disability reported in the year following a distal radius fracture: a cohort study.BMC Musculoskelet Disord. (2003) 4:24. 10.1186/1471-2474-4-24

  • 7.

    Ma XZ Zhang BS Wang ZD Wang MY . [Comparisons of clinical effects among three kinds of treatments of 1/3 displaced midshaft clavicular fractures in adults].Zhonghua Yi Xue Za Zhi. (2016) 96:259. 10.3760/cma.j.issn.0376-2491.2016.01.006

  • 8.

    Brinker MR Hanus BD Sen M O’Connor DP . The devastating effects of tibial nonunion on health-related quality of life.J Bone Joint Surg Am. (2013) 95:21706. 10.2106/jbjs.L.00803

  • 9.

    Ekegren CL Edwards ER Gabbe BJ . Incidence, costs and predictors of non-union, delayed union and mal-union following long bone fracture.Int J Environ Res Public Health. (2018) 15:2845. 10.3390/ijerph15122845

  • 10.

    Mills LA Aitken SA Simpson A . The risk of non-union per fracture: current myths and revised figures from a population of over 4 million adults.Acta Orthop. (2017) 88:4349. 10.1080/17453674.2017.1321351

  • 11.

    Moghaddam A Zimmermann G Hammer K Bruckner T Grützner PA von Recum J . Cigarette smoking influences the clinical and occupational outcome of patients with tibial shaft fractures.Injury. (2011) 42:143542. 10.1016/j.injury.2011.05.011

  • 12.

    Xiao Y Guangrong Y . 余霄译, and 俞光荣, 桡骨远端骨折的 AAOS 治疗指南 [AAOS guidelines for the treatment of distal radius fractures].中国矫形外科杂志 [Chinese J Orthopedics]. (2010) 18:188791. Chinese.

  • 13.

    Bahney CS Zondervan RL Allison P Theologis A Ashley JW Ahn J et al Cellular biology of fracture healing. J Orthop Res. (2019) 37:3550. 10.1002/jor.24170

  • 14.

    Zura R Xiong Z Einhorn T Watson JT Ostrum RF Prayson MJ et al Epidemiology of fracture nonunion in 18 human bones. JAMA Surg. (2016) 151:e162775. 10.1001/jamasurg.2016.2775

  • 15.

    Griffin XL Costa ML Parsons N Smith N . Electromagnetic field stimulation for treating delayed union or non-union of long bone fractures in adults.Cochrane Database Syst Rev. (2011) 4:Cd008471. 10.1002/14651858.CD008471.pub2

  • 16.

    Winocour SJ Schultz KP Davis MJ Abu-Ghname A Bohl M Ropper AE et al Vascularized posterior iliac crest bone grafting: indications, techniques, clinical outcomes, and alternatives. Semin Plast Surg. (2021) 35:3740. 10.1055/s-0041-1725986

  • 17.

    Berni M Brancato AM Torriani C Bina V Annunziata S Cornella E et al The role of low-level laser therapy in bone healing: systematic review. Int J Mol Sci. (2023) 24:7094. 10.3390/ijms24087094

  • 18.

    Chalidis B Sachinis N Assiotis A Maccauro G . Stimulation of bone formation and fracture healing with pulsed electromagnetic fields: biologic responses and clinical implications.Int J Immunopathol Pharmacol. (2011) 24:1720. 10.1177/03946320110241s204

  • 19.

    Khalifeh JM Zohny Z MacEwan M Stephen M Johnston W Gamble P et al Electrical stimulation and bone healing: a review of current technology and clinical applications. IEEE Rev Biomed Eng. (2018) 11:21732. 10.1109/rbme.2018.2799189

  • 20.

    Schandelmaier S Kaushal A Lytvyn L Heels-Ansdell D Siemieniuk RA Agoritsas T et al Low intensity pulsed ultrasound for bone healing: systematic review of randomized controlled trials. Bmj. (2017) 356:j656. 10.1136/bmj.j656

  • 21.

    Hutton B Salanti G Caldwell DM Chaimani A Schmid CH Cameron C et al The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. (2015) 162:77784. 10.7326/m14-2385

  • 22.

    Page MJ McKenzie JE Bossuyt PM Boutron I Hoffmann TC Mulrow CD et al The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. (2021) 372:n71. 10.1136/bmj.n71

  • 23.

    Hozo SP Djulbegovic B Hozo I . Estimating the mean and variance from the median, range, and the size of a sample.BMC Med Res Methodol. (2005) 5:13. 10.1186/1471-2288-5-13

  • 24.

    Sterne JAC Savović J Page MJ Elbers RG Blencowe NS Boutron I et al RoB 2: a revised tool for assessing risk of bias in randomised trials. Bmj. (2019) 366:l4898. 10.1136/bmj.l4898

  • 25.

    Dias S Welton NJ Sutton AJ Caldwell DM Lu G Ades AE . Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials.Med Decis Making. (2013) 33:64156. 10.1177/0272989x12455847

  • 26.

    Mills EJ Thorlund K Ioannidis JP . Demystifying trial networks and network meta-analysis.Bmj. (2013) 346:f2914. 10.1136/bmj.f2914

  • 27.

    Bois FY . Bayesian inference.Methods Mol Biol. (2013) 930:597636. 10.1007/978-1-62703-059-5_25

  • 28.

    Dias S Sutton AJ Welton NJ Ades AE. NICE Decision Support Unit Technical Support Documents, Heterogeneity: Subgroups, Meta-Regression, Bias And Bias-Adjustment. London: National Institute for Health and Care Excellence (2012).

  • 29.

    Hamra G MacLehose R Richardson D . Markov chain monte carlo: an introduction for epidemiologists.Int J Epidemiol. (2013) 42:62734. 10.1093/ije/dyt043

  • 30.

    Veroniki AA Vasiliadis HS Higgins JP Salanti G . Evaluation of inconsistency in networks of interventions.Int J Epidemiol. (2013) 42:33245. 10.1093/ije/dys222

  • 31.

    Rücker G Schwarzer G . Ranking treatments in frequentist network meta-analysis works without resampling methods.BMC Med Res Methodol. (2015) 15:58. 10.1186/s12874-015-0060-8

  • 32.

    Trinquart L Attiche N Bafeta A Porcher R Ravaud P . Uncertainty in treatment rankings: reanalysis of network meta-analyses of randomized trials.Ann Intern Med. (2016) 164:66673. 10.7326/m15-2521

  • 33.

    Jackson D Bujkiewicz S Law M Riley RD White IRA . matrix-based method of moments for fitting multivariate network meta-analysis models with multiple outcomes and random inconsistency effects.Biometrics. (2018) 74:54856. 10.1111/biom.12762

  • 34.

    Chaimani A Higgins JP Mavridis D Spyridonos P Salanti G . Graphical tools for network meta-analysis in STATA.PLoS One. (2013) 8:e76654. 10.1371/journal.pone.0076654

  • 35.

    Whegang Youdom S Tahar R Basco LK . Comparison of anti-malarial drugs efficacy in the treatment of uncomplicated malaria in African children and adults using network meta-analysis.Malar J. (2017) 16:311. 10.1186/s12936-017-1963-0

  • 36.

    Acosta-Olivo C Siller-Adame A Tamez-Mata A Vilchez-Cavazos F Peña-Martinez V Acosta-Olivo C . Laser treatment on acupuncture points improves pain and wrist functionality in patients undergoing rehabilitation therapy after wrist bone fracture. a randomized, controlled, blinded study.Acupunct Electrother Res. (2017) 42:1125. 10.3727/036012917x14908026365007

  • 37.

    Barker AT Dixon RA Sharrard WJ Sutcliffe ML . Pulsed magnetic field therapy for tibial non-union. Interim results of a double-blind trial.Lancet. (1984) 1:9946. 10.1016/s0140-6736(84)92329-8

  • 38.

    Beck BR Matheson GO Bergman G Norling T Fredericson M Hoffman AR et al Do capacitively coupled electric fields accelerate tibial stress fracture healing? A randomized controlled trial. Am J Sports Med. (2008) 36:54553. 10.1177/0363546507310076

  • 39.

    Busse JW Bhandari M Einhorn TA Schemitsch E Heckman JD Tornetta P et al Re-evaluation of low intensity pulsed ultrasound in treatment of tibial fractures (TRUST): randomized clinical trial. Bmj. (2016) 355:i5351. 10.1136/bmj.i5351

  • 40.

    Chang WD Wu JH Wang HJ Jiang JA . Therapeutic outcomes of low-level laser therapy for closed bone fracture in the human wrist and hand.Photomed Laser Surg. (2014) 32:2128. 10.1089/pho.2012.3398

  • 41.

    Cheing GL Wan JW Kai Lo S . Ice and pulsed electromagnetic field to reduce pain and swelling after distal radius fractures.J Rehabil Med. (2005) 37:3727. 10.1080/16501970510041055

  • 42.

    Duran E Durmaz B Atamaz F Kad MR Küçük L . Does interferential current provide additional benefit to orthopedic rehabilitation for the patients with proximal humeral fractures? A randomized controlled study.BMC Musculoskelet Disord. (2024) 25:114. 10.1186/s12891-024-07232-4

  • 43.

    Elboim-Gabyzon M Andrawus Najjar M Shtarker H . Effects of transcutaneous electrical nerve stimulation (TENS) on acute postoperative pain intensity and mobility after hip fracture: a double-blinded, randomized trial.Clin Interv Aging. (2019) 14:184150. 10.2147/cia.S203658

  • 44.

    Elsebahy SY Olama KA Elsayed MM . Low-intensity pulsed ultrasound for healing supracondylar fracture.Physiotherapy Quarterly. (2020) 28:159. 10.5114/PQ.2020.92473

  • 45.

    Factor S Druckmann I Atlan F Rosenblatt Y Tordjman D Krespi R et al The effects of novel pulsed electromagnetic field therapy device on acute distal radius fractures: a prospective, double-blind, sham-controlled, randomized pilot study. J Clin Med. (2023) 12:1866. 10.3390/jcm12051866

  • 46.

    Factor S Druckmann I Kazum E Atlan F Tordjman D Rosenblatt Y et al A novel pulsed electromagnetic field device as an adjunct therapy to surgical treatment of distal radius fractures: a prospective, double-blind, sham-controlled, randomized pilot study. Arch Orthop Trauma Surg. (2024) 144:54350. 10.1007/s00402-023-05117-0

  • 47.

    Fourie JA Bowerbank P . Stimulation of bone healing in new fractures of the tibial shaft using interferential currents.Physiother Res Int. (1997) 2:25568. 10.1002/pri.110

  • 48.

    Gopalan A Panneerselvam E Doss GT Ponvel K Raja K . Evaluation of efficacy of low intensity pulsed ultrasound in facilitating mandibular fracture healing-A blinded randomized controlled clinical trial.J Oral Maxillofac Surg. (2020) 78:997.e1e7. 10.1016/j.joms.2020.01.036

  • 49.

    Gorodetskyi IG Gorodnichenko AI Tursin PS Reshetnyak VK Uskov ON . Non-invasive interactive neurostimulation in the post-operative recovery of patients with a trochanteric fracture of the femur. A randomised, controlled trial.J Bone Joint Surg Br. (2007) 89:148894. 10.1302/0301-620x.89b11.19352

  • 50.

    Gorodetskyi IG Gorodnichenko AI Tursin PS Reshetnyak VK Uskov ON . Use of noninvasive interactive neurostimulation to improve short-term recovery in patients with surgically repaired bimalleolar ankle fractures: a prospective, randomized clinical trial.J Foot Ankle Surg. (2010) 49:4327. 10.1053/j.jfas.2010.05.007

  • 51.

    Hannemann PF Göttgens KW van Wely BJ Kolkman KA Werre AJ Poeze M et al The clinical and radiological outcome of pulsed electromagnetic field treatment for acute scaphoid fractures: a randomised double-blind placebo-controlled multicentre trial. J Bone Joint Surg Br. (2012) 94:14038. 10.1302/0301-620x.94b10.28844

  • 52.

    Hannemann PF van Wezenbeek MR Kolkman KA Twiss EL Berghmans CH Dirven PA et al CT scan-evaluated outcome of pulsed electromagnetic fields in the treatment of acute scaphoid fractures: a randomised, multicentre, double-blind, placebo-controlled trial. Bone Joint J. (2014) 96-B:10706. 10.1302/0301-620x.96b8.33767

  • 53.

    Heckman JD Ryaby JP McCabe J Frey JJ Kilcoyne RF . Acceleration of tibial fracture-healing by non-invasive, low-intensity pulsed ultrasound.J Bone Joint Surg Am. (1994) 76:2634. 10.2106/00004623-199401000-00004

  • 54.

    Kristiansen TK Ryaby JP McCabe J Frey JJ Roe LR . Accelerated healing of distal radial fractures with the use of specific, low-intensity ultrasound. A multicenter, prospective, randomized, double-blind, placebo-controlled study.J Bone Joint Surg Am. (1997) 79:96173. 10.2106/00004623-199707000-00002

  • 55.

    Liu W Jin X Guan Z Zhou Q . Pulsed electromagnetic field affects the development of postmenopausal osteoporotic women with vertebral fractures.Biomed Res Int. (2021) 2021:4650057. 10.1155/2021/4650057

  • 56.

    Liu Y Wei X Kuang Y Zheng Y Gu X Zhan H et al Ultrasound treatment for accelerating fracture healing of the distal radius. A control study. Acta Cir Bras. (2014) 29:76570. 10.1590/s0102-86502014001800012

  • 57.

    Martinez-Rondanelli A Martinez JP Moncada ME Manzi E Pinedo CR Cadavid H . Electromagnetic stimulation as coadjuvant in the healing of diaphyseal femoral fractures: a randomized controlled trial.Colomb Med. (2014) 45:6771. 10.25100/cm.v45i2.1479

  • 58.

    Mohajerani H Tabeie F Vossoughi F Jafari E Assadi M . Effect of pulsed electromagnetic field on mandibular fracture healing: a randomized control trial, (RCT).J Stomatol Oral Maxillofac Surg. (2019) 120:3906. 10.1016/j.jormas.2019.02.022

  • 59.

    Moncada ME Sarmiento C Martinez C Martinez A . Magnetic stimulation for fracture consolidation–clinical study.Annu Int Conf IEEE Eng Med Biol Soc. (2011) 2011:11414. 10.1109/iembs.2011.6090267

  • 60.

    Oncel M Sencan S Yildiz H Kurt N . Transcutaneous electrical nerve stimulation for pain management in patients with uncomplicated minor rib fractures.Eur J Cardiothorac Surg. (2002) 22:137. 10.1016/s1010-7940(02)00206-3

  • 61.

    Patel K Kumar S Kathiriya N Madan S Shah A Venkataraghavan K et al An evaluation of the effect of therapeutic ultrasound on healing of mandibular fracture. Craniomaxillofac Trauma Reconstr. (2015) 8:299306. 10.1055/s-0034-1544104

  • 62.

    Piazzolla A Bizzoca D Barbanti-Brodano G Formica M Pietrogrande L Tarantino U et al Capacitive biophysical stimulation improves the healing of vertebral fragility fractures: a prospective multicentre randomized controlled trial. J Orthop Traumatol. (2024) 25:17. 10.1186/s10195-024-00758-2

  • 63.

    Ricardo M . The effect of ultrasound on the healing of muscle-pediculated bone graft in scaphoid non-union.Int Orthop. (2006) 30:1237. 10.1007/s00264-005-0034-2

  • 64.

    Santana-Rodríguez N Clavo B Llontop P Fiuza MD Calatayud-Gastardi J López DD et al Pulsed ultrasounds reduce pain and disability, increasing rib fracture healing, in a randomized controlled trial. Pain Med. (2019) 20:19808. 10.1093/pm/pny224

  • 65.

    Schofer MD Block JE Aigner J Schmelz A . Improved healing response in delayed unions of the tibia with low-intensity pulsed ultrasound: results of a randomized sham-controlled trial.BMC Musculoskelet Disord. (2010) 11:229. 10.1186/1471-2474-11-229

  • 66.

    Scott G King JB . A prospective, double-blind trial of electrical capacitive coupling in the treatment of non-union of long bones.J Bone Joint Surg Am. (1994) 76:8206. 10.2106/00004623-199406000-00005

  • 67.

    Sharrard WJ . A double-blind trial of pulsed electromagnetic fields for delayed union of tibial fractures.J Bone Joint Surg Br. (1990) 72:34755. 10.1302/0301-620x.72b3.2187877

  • 68.

    Shi HF Xiong J Chen YX Wang JF Qiu XS Wang YH et al Early application of pulsed electromagnetic field in the treatment of postoperative delayed union of long-bone fractures: a prospective randomized controlled study. BMC Musculoskelet Disord. (2013) 14:35. 10.1186/1471-2474-14-35

  • 69.

    Simonis RB Parnell EJ Ray PS Peacock JL . Electrical treatment of tibial non-union: a prospective, randomised, double-blind trial.Injury. (2003) 34:35762. 10.1016/s0020-1383(02)00209-7

  • 70.

    Streit A Watson BC Granata JD Philbin TM Lin HN O’Connor JP et al Effect on clinical outcome and growth factor synthesis with adjunctive use of pulsed electromagnetic fields for fifth metatarsal nonunion fracture: a double-blind randomized study. Foot Ankle Int. (2016) 37:91923. 10.1177/1071100716652621

  • 71.

    Wang CJ Liu HC Fu TH . The effects of extracorporeal shockwave on acute high-energy long bone fractures of the lower extremity.Arch Orthop Trauma Surg. (2007) 127:13742. 10.1007/s00402-006-0236-0

  • 72.

    White NJ Patterson ED Dhaliwal GS Hildebrand KA . Low-intensity pulsed ultrasound versus sham in the treatment of operatively managed scaphoid nonunions: the SNAPU randomized controlled trial.J Bone Joint Surg Am. (2024) 106:157382. 10.2106/jbjs.23.00783

  • 73.

    Wu Y Zhou J Zhu F Zhang M Chen W . The effects of pain relief on proprioception and muscle strength for tibial plateau fractures: a randomized controlled trial.Musculoskelet Sci Pract. (2022) 62:102658. 10.1016/j.msksp.2022.102658

  • 74.

    Yadav YK Salgotra KR Banerjee A . Role of ultrasound therapy in the healing of tibial stress fractures.Med J Armed Forces India. (2008) 64:2346. 10.1016/s0377-1237(08)80101-3

  • 75.

    Pasero CL McCaffery M . Overcoming obstacles to pain assessment in elders.Am J Nurs. (1997) 97:20. 10.1097/00000446-199709000-00017

  • 76.

    Morrison SR Magaziner J McLaughlin MA Orosz G Silberzweig SB Koval KJ et al The impact of post-operative pain on outcomes following hip fracture. Pain. (2003) 103:30311. 10.1016/s0304-3959(02)00458-x

  • 77.

    Avci P Gupta A Sadasivam M Vecchio D Pam Z Pam N et al Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Semin Cutan Med Surg. (2013) 32:4152.

  • 78.

    Cardoso MV do Vale Placa R Sant’Ana ACP Greghi SLA Zangrando MS Rezende LR et al Laser and LED photobiomodulation effects in osteogenic or regular medium on rat calvaria osteoblasts obtained by newly forming bone technique. Lasers Med Sci. (2021) 36:54153. 10.1007/s10103-020-03056-5

  • 79.

    Nampo FK Cavalheri V Ramos S Camargo E . A. Effect of low-level phototherapy on delayed onset muscle soreness: a systematic review and meta-analysis.Lasers Med Sci. (2016) 31:16577. 10.1007/s10103-015-1832-4

  • 80.

    Sakata S Kunimatsu R Tsuka Y Nakatani A Gunji H Yanoshita M et al High-frequency near-infrared diode laser irradiation suppresses IL-1β-induced inflammatory cytokine expression and NF-κB signaling pathways in human primary chondrocytes. Lasers Med Sci. (2022) 37:1193201. 10.1007/s10103-021-03371-5

  • 81.

    Rodríguez-Merchán EC . A review of recent developments in the molecular mechanisms of bone healing.Int J Mol Sci. (2021) 22:767. 10.3390/ijms22020767

  • 82.

    Kazem Shakouri S Soleimanpour J Salekzamani Y Oskuie MR . Effect of low-level laser therapy on the fracture healing process.Lasers Med Sci. (2010) 25:737. 10.1007/s10103-009-0670-7

  • 83.

    Renno AC McDonnell PA Parizotto NA Laakso EL . The effects of laser irradiation on osteoblast and osteosarcoma cell proliferation and differentiation in vitro.Photomed Laser Surg. (2007) 25:27580. 10.1089/pho.2007.2055

  • 84.

    Schmidt-Bleek K Schell H Schulz N Hoff P Perka C Buttgereit F et al Inflammatory phase of bone healing initiates the regenerative healing cascade. Cell Tissue Res. (2012) 347:56773. 10.1007/s00441-011-1205-7

  • 85.

    Fekrazad R Sadeghi Ghuchani M Eslaminejad MB Taghiyar L Kalhori KA Pedram MS et al The effects of combined low level laser therapy and mesenchymal stem cells on bone regeneration in rabbit calvarial defects. J Photochem Photobiol B. (2015) 151:1805. 10.1016/j.jphotobiol.2015.08.002

  • 86.

    Breit R Van der Wall H . Transcutaneous electrical nerve stimulation for postoperative pain relief after total knee arthroplasty.J Arthroplasty. (2004) 19:458. 10.1016/s0883-5403(03)00458-3

  • 87.

    Sluka KA Bjordal JM Marchand S Rakel BA . What makes transcutaneous electrical nerve stimulation work? Making sense of the mixed results in the clinical literature.Phys Ther. (2013) 93:1397402. 10.2522/ptj.20120281

  • 88.

    Kalra A Urban MO Sluka KA . Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS).J Pharmacol Exp Ther. (2001) 298:25763. 10.1016/s0022-3565(24)29376-9

  • 89.

    Lord SR Murray SM Chapman K Munro B Tiedemann A . Sit-to-stand performance depends on sensation, speed, balance, and psychological status in addition to strength in older people.J Gerontol A Biol Sci Med Sci. (2002) 57:M53943. 10.1093/gerona/57.8.m539

  • 90.

    Sluka KA Walsh D . Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness.J Pain. (2003) 4:10921. 10.1054/jpai.2003.434

  • 91.

    Hussein HM Alshammari RS Al-Barak SS Alshammari ND Alajlan SN Althomali OWA . Systematic review and meta-analysis investigating the pain-relieving effect of interferential current on musculoskeletal pain.Am J Phys Med Rehabil. (2022) 101:62433. 10.1097/phm.0000000000001870

  • 92.

    Fuentes JP Armijo Olivo S Magee DJ Gross DP . Effectiveness of interferential current therapy in the management of musculoskeletal pain: a systematic review and meta-analysis.Phys Ther. (2010) 90:121938. 10.2522/ptj.20090335

  • 93.

    Rampazo Liebano RE . Analgesic effects of interferential current therapy: a narrative review.Medicina. (2022) 58:141. 10.3390/medicina58010141

  • 94.

    Urita A Iwasaki N Kondo M Nishio Y Kamishima T Minami A . Effect of low-intensity pulsed ultrasound on bone healing at osteotomy sites after forearm bone shortening.J Hand Surg Am. (2013) 38:498503. 10.1016/j.jhsa.2012.11.032

  • 95.

    Nolte PA Klein-Nulend J Albers GH Marti RK Semeins CM Goei SW et al Low-intensity ultrasound stimulates endochondral ossification in vitro. J Orthop Res. (2001) 19:3017. 10.1016/s0736-0266(00)00027-9

  • 96.

    Thompson Z Miclau T Hu D Helms JAA . model for intramembranous ossification during fracture healing.J Orthop Res. (2002) 20:10918. 10.1016/s0736-0266(02)00017-7

  • 97.

    Chen YJ Wang CJ Yang KD Chang PR Huang HC Huang YT et al Pertussis toxin-sensitive Galphai protein and ERK-dependent pathways mediate ultrasound promotion of osteogenic transcription in human osteoblasts. FEBS Lett. (2003) 554:1548. 10.1016/s0014-5793(03)01157-8

  • 98.

    Harrison A Lin S Pounder N Mikuni-Takagaki Y . Mode & mechanism of low intensity pulsed ultrasound (LIPUS) in fracture repair.Ultrasonics. (2016) 70:4552. 10.1016/j.ultras.2016.03.016

  • 99.

    Tang CH Yang RS Huang TH Lu DY Chuang WJ Huang TF et al Ultrasound stimulates cyclooxygenase-2 expression and increases bone formation through integrin, focal adhesion kinase, phosphatidylinositol 3-kinase, and Akt pathway in osteoblasts. Mol Pharmacol. (2006) 69:204757. 10.1124/mol.105.022160

  • 100.

    Yang RS Lin WL Chen YZ Tang CH Huang TH Lu BY et al Regulation by ultrasound treatment on the integrin expression and differentiation of osteoblasts. Bone. (2005) 36:27683. 10.1016/j.bone.2004.10.009

  • 101.

    Ardan NI Janes JM Herrick JF . Ultrasonic energy and surgically produced defects in bone.J Bone Joint Surg Am. (1957) 39-A:394402. 10.2106/00004623-195739020-00013

  • 102.

    Bender LF Janes JM Herrick JF . Histologic studies following exposure of bone to ultrasound.Arch Phys Med Rehabil. (1954) 35:5559.

  • 103.

    Warden SJ Fuchs RK Kessler CK Avin KG Cardinal RE Stewart RL . Ultrasound produced by a conventional therapeutic ultrasound unit accelerates fracture repair.Phys Ther. (2006) 86:111827. 10.1093/ptj/86.8.1118

  • 104.

    Watanabe Y Matsushita T Bhandari M Zdero R Schemitsch EH . Ultrasound for fracture healing: current evidence.J Orthop Trauma. (2010) 24:S5661. 10.1097/BOT.0b013e3181d2efaf

  • 105.

    Lai CH Chuang CC Li JK Chen SC Chang WH . Effects of ultrasound on osteotomy healing in a rabbit fracture model.Ultrasound Med Biol. (2011) 37:163543. 10.1016/j.ultrasmedbio.2011.06.014

  • 106.

    Yang KH Parvizi J Wang SJ Lewallen DG Kinnick RR Greenleaf JF et al Exposure to low-intensity ultrasound increases aggrecan gene expression in a rat femur fracture model. J Orthop Res. (1996) 14:8029. 10.1002/jor.1100140518

  • 107.

    Tam KF Cheung WH Lee KM Qin L Leung KS . Osteogenic effects of low-intensity pulsed ultrasound, extracorporeal shockwaves and their combination - an in vitro comparative study on human periosteal cells.Ultrasound Med Biol. (2008) 34:195765. 10.1016/j.ultrasmedbio.2008.06.005

  • 108.

    Pounder NM Harrison AJ . Low intensity pulsed ultrasound for fracture healing: a review of the clinical evidence and the associated biological mechanism of action.Ultrasonics. (2008) 48:3308. 10.1016/j.ultras.2008.02.005

  • 109.

    Rawool NM Goldberg BB Forsberg F Winder AA Hume E . Power Doppler assessment of vascular changes during fracture treatment with low-intensity ultrasound.J Ultrasound Med. (2003) 22:14553. 10.7863/jum.2003.22.2.145

  • 110.

    Palanisamy P Alam M Li S Chow SKH Zheng YP . Low-intensity pulsed ultrasound stimulation for bone fractures healing: a review.J Ultrasound Med. (2022) 41:54763. 10.1002/jum.15738

  • 111.

    Kokubu T Matsui N Fujioka H Tsunoda M Mizuno K . Low intensity pulsed ultrasound exposure increases prostaglandin E2 production via the induction of cyclooxygenase-2 mRNA in mouse osteoblasts.Biochem Biophys Res Commun. (1999) 256:2847. 10.1006/bbrc.1999.0318

  • 112.

    Yuan J Xin F Jiang W . Underlying signaling pathways and therapeutic applications of pulsed electromagnetic fields in bone repair.Cell Physiol Biochem. (2018) 46:158194. 10.1159/000489206

  • 113.

    Peng L Fu C Xiong F Zhang Q Liang Z Chen L et al Effectiveness of pulsed electromagnetic fields on bone healing: a systematic review and meta-analysis of randomized controlled trials. Bioelectromagnetics. (2020) 41:32337. 10.1002/bem.22271

  • 114.

    Bagheri L Pellati A Rizzo P Aquila G Massari L De Mattei M et al Notch pathway is active during osteogenic differentiation of human bone marrow mesenchymal stem cells induced by pulsed electromagnetic fields. J Tissue Eng Regen Med. (2018) 12:30415. 10.1002/term.2455

  • 115.

    Ehnert S Falldorf K Fentz AK Ziegler P Schröter S Freude T et al Primary human osteoblasts with reduced alkaline phosphatase and matrix mineralization baseline capacity are responsive to extremely low frequency pulsed electromagnetic field exposure - Clinical implication possible. Bone Rep. (2015) 3:4856. 10.1016/j.bonr.2015.08.002

  • 116.

    Kuzyk PR Schemitsch EH . The science of electrical stimulation therapy for fracture healing.Indian J Orthop. (2009) 43:12731. 10.4103/0019-5413.50846

  • 117.

    Selvamurugan N He Z Rifkin D Dabovic B Partridge NC . Pulsed electromagnetic field regulates MicroRNA 21 expression to activate TGF-β signaling in human bone marrow stromal cells to enhance osteoblast differentiation.Stem Cells Int. (2017) 2017:2450327. 10.1155/2017/2450327

  • 118.

    Cadossi R Massari L Racine-Avila J Aaron RK . Pulsed electromagnetic field stimulation of bone healing and joint preservation: cellular mechanisms of skeletal Response.J Am Acad Orthop Surg Glob Res Rev. (2020) 4:e1900155. 10.5435/JAAOSGlobal-D-19-00155

  • 119.

    Ribatti D . The discovery of the placental growth factor and its role in angiogenesis: a historical review.Angiogenesis. (2008) 11:21521. 10.1007/s10456-008-9114-4

  • 120.

    Kermani P Hempstead B . Brain-derived neurotrophic factor: a newly described mediator of angiogenesis.Trends Cardiovasc Med. (2007) 17:1403. 10.1016/j.tcm.2007.03.002

  • 121.

    Parhampour B Torkaman G Hoorfar H Hedayati M Ravanbod R . Effects of short-term resistance training and pulsed electromagnetic fields on bone metabolism and joint function in severe haemophilia A patients with osteoporosis: a randomized controlled trial.Clin Rehabil. (2014) 28:44050. 10.1177/0269215513505299

  • 122.

    Rossini M Viapiana O Gatti D de Terlizzi F Adami S . Capacitively coupled electric field for pain relief in patients with vertebral fractures and chronic pain.Clin Orthop Relat Res. (2010) 468:73540. 10.1007/s11999-009-1088-z

  • 123.

    Brighton CT Wang W Seldes R Zhang G Pollack SR . Signal transduction in electrically stimulated bone cells.J Bone Joint Surg Am. (2001) 83:151423. 10.2106/00004623-200110000-00009

  • 124.

    Clark CC Wang W Brighton CT . Up-regulation of expression of selected genes in human bone cells with specific capacitively coupled electric fields.J Orthop Res. (2014) 32:894903. 10.1002/jor.22595

  • 125.

    Zhuang H Wang W Seldes RM Tahernia AD Fan H Brighton CT . Electrical stimulation induces the level of TGF-beta1 mRNA in osteoblastic cells by a mechanism involving calcium/calmodulin pathway.Biochem Biophys Res Commun. (1997) 237:2259. 10.1006/bbrc.1997.7118

  • 126.

    Wu X Zeng LH Taniguchi T Xie QM . Activation of PKA and phosphorylation of sodium-dependent vitamin C transporter 2 by prostaglandin E2 promote osteoblast-like differentiation in MC3T3-E1 cells.Cell Death Differ. (2007) 14:1792801. 10.1038/sj.cdd.4402190

  • 127.

    Brighton CT Hozack WJ Brager MD Windsor RE Pollack SR Vreslovic EJ et al Fracture healing in the rabbit fibula when subjected to various capacitively coupled electrical fields. J Orthop Res. (1985) 3:33140. 10.1002/jor.1100030310

  • 128.

    Zhang L Fu XB Chen S Zhao ZB Schmitz C Weng CS . Efficacy and safety of extracorporeal shock wave therapy for acute and chronic soft tissue wounds: a systematic review and meta-analysis.Int Wound J. (2018) 15:5909. 10.1111/iwj.12902

  • 129.

    Ahmed Z Wieraszko A . Combined effects of acrobatic exercise and magnetic stimulation on the functional recovery after spinal cord lesions.J Neurotrauma. (2008) 25:125769. 10.1089/neu.2008.0626

  • 130.

    Pain Medicine Branch of Chinese Medical Doctor Association, National Key Clinical Specialty, China-Japan Friendship Hospital Pain Specialist Medical Alliance, Beijing Pain Treatment Quality Control and Improvement Center. 慢性肌肉骨骼疼痛的药物治疗专家共识 [Expert consensus on drug treatment of chronic musculoskeletal pain]. 中国疼痛医学杂志 [Chinese J Pain Med]. (2018) 24: 8817. Chinese.

Summary

Keywords

physical agent modalities, fracture, bone healing, pain relief, network meta-analysis

Citation

Li L, Yang L, Yang Y, Zhu J, Shi R, Deng Q, Wang J and Sun F (2025) Evaluation of the efficacy of physical agent modalities in patients with fractures: a systematic review and network meta-analysis. Front. Med. 12:1646903. doi: 10.3389/fmed.2025.1646903

Received

14 June 2025

Accepted

16 October 2025

Published

29 October 2025

Volume

12 - 2025

Edited by

Pedro Morouço, Clínica Espregueira - FIFA Medical Centre of Excellence, Portugal

Reviewed by

Federica Buccino, Fondazione Politecnico di Milano, Italy

Jonathan Koa, Thomas Jefferson University, United States

Updates

Copyright

*Correspondence: Jianxiong Wang, Fuhua Sun,

†These authors share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics